Skip to content
Search

Latest Stories

Revalidation: Pharmacists need to file only reflective account until February 2022

Pharmacists and pharmacy technicians due to submit their revalidation records from December 2021 only need to present a reflective account until February 2022, the General Pharmaceutical Council (GPhC) has said.

The regulator said it has decided to extend the changes to its revalidation requirements made in March 2020 “in recognition of the continuing pressures linked to the Covid-19 pandemic that pharmacy professionals are likely to face this winter”.


After introducing the alteration last year, it was then extended until November 2021.

Duncan Rudkin, chief executive of the GPhC, said: “This extension will continue until at least the end of February 2022. We will give pharmacy professionals a minimum of three months’ notice of when full revalidation requirements will be reintroduced, to give pharmacists and pharmacy professionals a reasonable amount of time to get their records ready for submission.

“Our current intention is to resume full revalidation once the emergency powers for the pandemic introduced by the secretary of state for health and social care are removed, but we will continue to keep this under active review.”

Therefore, pharmacy registrants who need to renew their registration in December, January or February are exempt from submitting the other five revalidation records, the GPhC stated.

However, pharmacy professionals are still expected to reflect on one or more of the following three standards when completing their reflective account:

  • standard 3 - pharmacy professionals must communicate effectively
  • standard 6 - pharmacy professionals must behave professionally
  • standard 9 - pharmacy professionals must demonstrate leadership.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
New CPCF funding: “This is the best deal community pharmacy has had in a decade”

This new funding settlement marks a significant step forward in addressing the long term underinvestment in community pharmacy, says RPS England chair Tase Oputu

Pharmacy bodies hail new funding settlement as ‘best deal for community pharmacy in a decade’

Pharmacy bodies have welcomed the new funding settlement for community pharmacies, highlighting its potential to enhance patient access to care and medicines while addressing a decade of underinvestment in the sector.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a record £3.073 billion funding package for 2025/26, along with an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less